Brown W J, DeWald D B, Emr S D, Plutner H, Balch W E
Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, New York 14853, USA.
J Cell Biol. 1995 Aug;130(4):781-96. doi: 10.1083/jcb.130.4.781.
Previous work with the yeast Saccharomyces cerevisiae has demonstrated a role for a phosphatidylinositol-specific PI 3-kinase, the product of the VPS34 gene, in the targeting of newly synthesized proteins to the vacuole, an organelle functionally equivalent to mammalian lysosomes (Schu, P. V., K. Takegawa, M. J. Fry, J. H. Stack, M. D. Waterfield, and S. D. Emr. 1993. Science [Wash. DC]. 260:88-91). The activity of Vps34p kinase is significantly reduced by the PI 3-kinase inhibitors wortmannin, a fungal metabolite, and LY294002, a quercetin analog (Stack, J. H., and S. D. Emr. 1994. J. Biol. Chem. 269:31552-31562). We show here that at concentrations which inhibit VPS34-encoded PI 3-kinase activity, wortmannin also inhibits the processing and delivery of newly synthesized cathepsin D to lysosomes in mammalian cells with half-maximal inhibition of delivery occurring at 100 nM wortmannin. As a result of wortmannin action, newly synthesized, unprocessed cathepsin D is secreted into the media. Moreover, after accumulation in the trans-Golgi network (TGN) at 20 degrees C, cathepsin D was rapidly missorted to the secretory pathway after addition of wortmannin and shifting to 37 degrees C. At concentrations that inhibited lysosomal enzyme delivery, both wortmannin and LY294002 caused a highly specific dilation of mannose 6-phosphate receptor (M6PR)-enriched vesicles of the prelysosome compartment (PLC), which swelled to approximately 1 micron within 15 min after treatment. With increasing time, the inhibitors caused a significant yet reversible change in M6PR distribution. By 3 h of treatment, the swollen PLC vacuoles were essentially depleted of receptors and, in addition, there was a fourfold loss of receptors from the cell surface. However, M6PRs were still abundant in the TGN. These results are most consistent with the interpretation that PI 3-kinase regulates the trafficking of lysosomal enzymes by interfering with a M6PR-dependent sorting event in the TGN. Moreover, they provide evidence that trafficking of soluble hydrolases to mammalian lysosomes and yeast vacuoles rely on similar regulatory mechanisms.
先前对酿酒酵母的研究表明,磷脂酰肌醇特异性PI 3激酶(VPS34基因的产物)在将新合成的蛋白质靶向液泡过程中发挥作用,液泡是一种在功能上等同于哺乳动物溶酶体的细胞器(舒,P.V.,K.武川,M.J.弗莱,J.H.斯塔克,M.D.沃特菲尔德,和S.D.埃姆尔。1993年。《科学》[华盛顿特区]。260:88 - 91)。PI 3激酶抑制剂渥曼青霉素(一种真菌代谢产物)和LY294002(一种槲皮素类似物)可显著降低Vps34p激酶的活性(斯塔克,J.H.,和S.D.埃姆尔。1994年。《生物化学杂志》。269:31552 - 31562)。我们在此表明,在抑制VPS34编码的PI 3激酶活性的浓度下,渥曼青霉素也会抑制新合成的组织蛋白酶D在哺乳动物细胞中向溶酶体的加工和转运,渥曼青霉素浓度为100 nM时对转运的抑制作用达到半数最大抑制。由于渥曼青霉素的作用,新合成的未加工组织蛋白酶D被分泌到培养基中。此外,在20℃下于反式高尔基体网络(TGN)中积累后,添加渥曼青霉素并转移至37℃后,组织蛋白酶D迅速被错误分选至分泌途径。在抑制溶酶体酶转运的浓度下,渥曼青霉素和LY294002均导致富含甘露糖6 - 磷酸受体(M6PR)的前溶酶体区室(PLC)囊泡发生高度特异性扩张,处理后15分钟内囊泡膨胀至约1微米。随着时间延长,抑制剂导致M6PR分布发生显著但可逆的变化。处理3小时后,肿胀的PLC液泡基本耗尽受体,此外,细胞表面的受体减少了四倍。然而,M6PR在TGN中仍然丰富。这些结果最符合以下解释:PI 3激酶通过干扰TGN中依赖M6PR的分选事件来调节溶酶体酶的运输。此外,它们提供了证据表明可溶性水解酶向哺乳动物溶酶体和酵母液泡的运输依赖于相似的调节机制。